In a report released today, Vamil Divan from Guggenheim reiterated a Buy rating on Johnson & Johnson, with a price target of $206.00. The company’s shares opened today at $188.87. Take advantage of ...
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback